Artículos de revistas
Nasal Vaccination With Attenuated Salmonella Expressing Vapa: Tlr2 Activation Is Not Essential For Protection Against R. Equi Infection
Registro en:
Vaccine. , v. 31, n. 41, p. 4528 - 4535, 2013.
0264410X
10.1016/j.vaccine.2013.07.067
2-s2.0-84883597741
Autor
Cardoso S.A.
Oliveira A.F.
Ruas L.P.
Trevisani M.M.
De Oliveira L.L.
Hanna E.S.
Roque-Barreira M.C.
Soares S.G.
Institución
Resumen
Virulent strains of Rhodococcus equi have a large plasmid of 80-90kb, which encodes several virulence-associated proteins (Vap), including VapA, a lipoprotein highly associated with disease. We have previously demonstrated that oral immunisation with attenuated Salmonella enterica Typhimurium strain expressing the antigen VapA (STM VapA+) induces specific and long-term humoral and cellular immunity against R. equi. It was shown that VapA activates Toll-like receptor 2 (TLR2) on macrophages by establishing an interaction that ultimately favours immunity against R. equi infection. The purpose of this study was to evaluate the immune response triggered by nasal immunisation with STM VapA+ and to determine whether TLR2 supports the vaccine effect. We developed an optimised protocol for a single nasal immunisation that conferred protection against R. equi infection in mice, which was manifested by efficient R. equi clearance in challenged animals. Nasal vaccination with STM VapA+ has also induced protection in Tlr2-/- mice and mice with non-functional TLR4. Moreover, spleen cells of vaccinated mice augmented T-bet expression, as well as the production of IL-12, IFN-γ, nitric oxide and hydrogen peroxide. Notably, the population of CD4+ T cells with memory phenotype significantly increased in the spleens of vaccinated mice challenged 1 or 5 months after immunisation. In these animals, the spleen bacterial burden was also reduced. When similar experimental procedures were performed in TLR2 knockout mice, an increase in CD4+ T cells with memory phenotype was not observed. Consequently, we conclude that nasal vaccination with attenuated Salmonella expressing the R. equi virulence factor VapA confers long-lasting protection against experimental rhodoccocosis and that TLR2 engagement was not crucial to induce this protection but may be required for a long-term immune response. © 2013 Elsevier Ltd. 31 41 4528 4535 Cornish, N., Washington, J.A., Rhodococcus equi infections: clinical features and laboratory diagnosis (1999) Current Clinical Topics in Infectious Diseases, 19, pp. 198-215 Prescott, J.F., Rhodococcus equi: an animal and human pathogen (1991) Clinical Microbiology Reviews, 4, pp. 20-34 Giguère, S., Cohen, N.D., Chaffin, M.K., Hines, S.A., Hondalus, M.K., Prescott, J.F., Rhodococcus equi: clinical manifestations, virulence, and immunity (2011) Journal of Veterinary Internal Medicine, 25 (6), pp. 1221-1230 Takai, S., Koike, K., Ohbushi, S., Izumi, C., Tsubaki, S., Identification of 15- to 17-kilodalton antigens associated with virulent Rhodococcus equi (1991) Journal of Clinical Microbiology, 29, pp. 439-443 Jain, S., Bloom, B.R., Hondalus, M.K., Deletion of vapA encoding virulence associated protein A attenuates the intracellular actinomycete Rhodococcus equi (2003) Molecular Microbiology, 50, pp. 115-128 Hooper-McGrevy, K.E., Giguere, S., Wilkie, B.N., Prescott, J.F., Evaluation of equine immunoglobulin specific Rhodococcus equi virulence-associated proteins A and C for use in protecting foals against Rhodococcus equi-induced pneumonia (2001) American Journal of Veterinary Research, 62, pp. 1307-1313 Taouji, S., Nomura, I., Giguere, S., Tomomitsu, S., Kakuda, T., Ganne, V., Immunogenicity of synthetic peptides representing B cell epitopes of VapA of Rhodococcus equi (2004) Vaccine, 22, pp. 1114-1122 Oliveira, A.F., Ferraz, L.C., Brocchi, M., Roque-Barreira, M.C., Oral administration of a live attenuated Salmonella vaccine strain expressing the VapA protein induces protection against infection by Rhodococcus equi (2007) Microbes and Infection, 9, pp. 382-390 Oliveira, A.F., Ruas, L.P., Cardoso, A.S., Soares, S.G., Roque-Barreira, M.C., Vaccination of mice with Salmonella expressing VapA: mucosal and systemic Th1 responses provide protection against Rhodococcus equi infection (2010) PLoS ONE, 5, pp. 1-12 Prescott, J.F., Nicholson, V.M., Patterson, M.C., Zandona Meleiro, M.C., Caterino de Araujo, A., Yager, J.A., Use of Rhodococcus equi virulence-associated protein for immunization of foals against R. equi pneumonia (1997) American Journal of Veterinary Research, 58, pp. 356-359 Varga, J., Fodor, L., Rusval, M., Soos, I., Makrai, L., Prevention of Rhodococcus equi pneumonia of foals using two different inactivated vaccines (1997) Veterinary Microbiology, 56, pp. 205-212 Haghighi, H.R., Prescott, J.F., Assessment in mice of VapA-DNA vaccination against Rhodococcus equi infection (2005) Veterinary Immunology and Immunopathology, 104, pp. 215-225 van der Geize, R., Grommen, A.W.F., Hessels, G.I., Jacobs, A.A.C., Dijkhuizen, L., The steroid catabolic pathway of the intracellular pathogen Rhodococcus equi is important for pathogenesis and a target for vaccine development (2011) PLoS Pathogens, 7 (8), pp. e1002181 Kiyono, H., Fukuyama, S., NALT- versus Peyer's-patch-mediated mucosal immunity (2004) Nature Reviews Immunology, 4, pp. 699-710 Hiroi, T., Iwatani, K., Iijima, H., Kodama, S., Yanagita, M., Kiyono, H., Nasal immune system: distinctive Th0 and Th1/Th2 type environments in murine nasal-associated lymphoid tissues and nasal passage, respectively (1998) European Journal of Immunology, 28 (10), pp. 3346-3353 Pasetti, M.F., Pickett, T.E., Levine, M.M., Sztein, M.B., A comparison of immunogenicity and in vivo distribution of Salmonella entérica serovar Typhi and Typhimurium live vector vaccines delivered by mucosal routes in the murine model (2000) Vaccine, 18 (28), pp. 3208-3213 Kim, D.Y., Sato, A., Fukuyama, S., Sagara, H., Nagatake, T., Kong, I.G., The airway antigen sampling system: respiratory M cells as an alternative gateway for inhaled antigens (2011) Journal of Immunology, 186 (7), pp. 4253-4262 Roche, J.K., Rojo, A.L., Costa, L.B., Smeltz, R., Manque, P., Woehlbier, U., Intranasal vaccination in mice with an attenuated Salmonella enterica Serovar 908htr A expressing Cp15 of Cryptosporidium: impact of malnutrition with preservation of cytokine secretion (2013) Vaccine, 31 (6), pp. 912-918 Scavone, P., Umpiérrez, A., Maskell, D.J., Zunino, P., Nasal immunization with attenuated Salmonella Typhimurium expressing an MrpA-TetC fusion protein significantly reduces Proteus mirabilis colonization in the mouse urinary tract (2011) Journal of Medical Microbiology, 60 (PART. 7), pp. 899-904 Causey, R.C., Artiushin, S.C., Crowley, I.F., Weber, J.A., Homola, A.D., Kelley, A., Immunisation of the equine uterus against Streptococcus equi subspecies zooepidemicus using an intranasal attenuated Salmonella vector (2010) Veterinary Journal, 184 (2), pp. 156-161 Darrah, P.A., Monaco, M.C.G., Jain, S., Hondalus, M.K., Golenbock, D.T., Mosser, D.M., Innate immune responses to Rhodococcus equi (2004) Journal of Immunology, 173, pp. 1914-1924 Cottalorda, A., Verschelde, C., Marcais, A., Tomkowiak, M., Musette, P., Uematsu, S., TLR2 engagement on CD8T cells lowers the threshold for optimal antigen-induced T cell activation (2006) European Journal of Immunology, 36, pp. 1684-1693 Komai-Koma, M., Jones, L., Ogg, G.S., Xu, D., Liew, F.Y., TLR2 is expressed on activated T cells as a costimulatory receptor (2004) Proceedings of the National Academy of Sciences of the United States of America, 101, pp. 3029-3034 Gelman, A.E., Zhang, J., Choi, Y., Turka, L.A., Toll-like receptor ligands directly promote activated CD4+ T cell survival (2004) Journal of Immunology, 172, pp. 6065-6073 Cottalorda, A., Mercier, B.C., Mbitikon-Kobo, F.M., Arpin, C., Teoh, D.Y., McMichael, A., TLR2 engagement on memory CD8+ T cells improves their cytokine-mediated proliferation and IFN-gamma secretion in the absence of Ag (2009) European Journal of Immunology, 39, pp. 2673-2681